Filtering the solution can help remove aggregated particles and improve overall peptide solubility
SURMOUNT-1 Trial (72-Week Duration, 2,539 Participants): Average weight loss with 15 mg: 20.9% of body weight Participants losing 5%: 91% Participants losing 10%: 82% Participants losing 20%: 57% SURMOUNT-2 Trial (People with Type 2 Diabetes): Average weight loss with 15 mg: 15.7% A1C reduction: 2.0 percentage points Source: Jastreboff AM, et al
During the protocol, no lesion occurred on the injection area and the patient continued to use the drug in one injection per application in the following days without any reaction
10.7150/thno.54113 179 XianM.WangQ.XiaoL.ZhongL.XiongW.YeL.et al (2024)
The ability to help a significant proportion of patients with T2D achieve normoglycemia without an increased risk of hypoglycemia represents a paradigm shift, moving the therapeutic goal from mere control towards potential disease remission
Frequently Asked Questions Which medication causes more weight loss: semaglutide or tirzepatide
